单位(元)天弘医药创新C(010655)利润表 |
报告期 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
收入 |
-168,479,563 |
-177,836,234 |
-161,509,550 |
-197,187,215 |
利息收入 |
498,393 |
270,194 |
556,207 |
273,326 |
其中:存款利息收入 |
498,393 |
270,194 |
556,207 |
273,326 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益 |
-18,193,708 |
-43,517,734 |
-170,341,096 |
-202,028,623 |
其中:股票投资收益 |
-26,350,018 |
-49,778,799 |
-177,025,076 |
-206,116,441 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
- |
- |
- |
- |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
8,156,311 |
6,261,065 |
6,683,981 |
4,087,818 |
公允价值变动收益 |
-151,385,603 |
-134,983,910 |
7,556,512 |
4,218,278 |
汇兑收益 |
- |
- |
- |
- |
其他收入 |
601,355 |
395,216 |
718,827 |
349,804 |
费用 |
17,099,800 |
9,236,174 |
15,833,595 |
7,700,560 |
管理人报酬 |
12,303,399 |
6,550,949 |
11,374,229 |
5,527,912 |
托管费 |
2,814,178 |
1,637,737 |
2,843,557 |
1,381,978 |
销售服务费 |
1,738,279 |
925,795 |
1,376,969 |
677,176 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
243,944 |
121,692 |
238,839 |
113,494 |
利润总额 |
-185,579,363 |
-187,072,408 |
-177,343,144 |
-204,887,775 |
减:所得税费用 |
- |
- |
- |
- |
净利润 |
-185,579,363 |
-187,072,408 |
-177,343,144 |
-204,887,775 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。